Colyte 81.2 mg (Sodium Sulfate POWDER FOR SOLUTION) 81.2 MG

Colyte 81.2 mg is an oral powder solution used for bowel cleansing before medical procedures. This sodium sulfate-based preparation helps clear the intestines for better visibility during colonoscopies or surgeries.

Strength

81.2 MG

Pack Size

278G PER 4L

Manufacturer / TM Owner

PENDOPHARM DIVISION OF PHARMASCIENCE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Colyte 81.2 mg is primarily used for bowel preparation before colonoscopies or surgeries. It works by cleansing the intestines to ensure clear visibility. This sodium sulfate solution is designed for oral administration and is commonly prescribed for patients undergoing colon-related medical procedures.

Side Effects

When taken as directed, Colyte 81.2 mg typically causes frequent bowel movements, leading to complete bowel evacuation. Some users may experience mild discomfort or bloating as the solution works to clear the intestines.

Precautions & Warnings

It is important to follow the instructions provided by your healthcare professional when using Colyte 81.2 mg. Ensure you stay hydrated and avoid taking other medications within a certain timeframe before or after using this solution. Always consult your healthcare provider for personalized advice.

Avoid Interactions

Colyte 81.2 mg may interact with certain medications, so it is advisable to inform your healthcare provider about all the medications you are currently taking. Avoid consuming alcohol or other substances that could interfere with the effectiveness of the solution.

Frequently Asked Questions

Colyte 81.2 mg is used for bowel cleansing before medical procedures like colonoscopies or surgeries.

Colyte 81.2 mg is taken orally as a powder solution. Follow the instructions provided by your healthcare professional for proper administration.

Common effects include frequent bowel movements and possible mild discomfort or bloating.

It is advisable to consult your healthcare provider about taking other medications with Colyte 81.2 mg to avoid potential interactions.

Store Colyte 81.2 mg at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.